Clinical features of postoperative chylothorax for lung cancer and esophageal cancer.
- Author:
Jun ZHAO
1
;
De-chao ZHANG
;
Liang-jun WANG
;
Ru-gang ZHANG
Author Information
- Publication Type:Journal Article
- MeSH: Adult; Aged; Chylothorax; etiology; therapy; Esophageal Neoplasms; surgery; Female; Humans; Lung Neoplasms; surgery; Male; Middle Aged; Postoperative Complications; etiology
- From: Chinese Journal of Surgery 2003;41(1):47-49
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo define the clinical features of postoperative chylothorax for lung cancer (PCLC), and to compare them with those for esophageal cancer (PCEC).
METHODWe retrospectively analysed clinical characteristics of 12 patients with chylothorax among 4 084 patients receiving resection of lung cancer, as well as 52 in 4 479 patients having resection of esophageal cancer since 1985 at our hospital.
RESULTSThe incidence of PCLC was 0.29% and that of PCEC was 1.16%. The percentage of diagnosis confirmed within 4 postoperative days was 33.3% for PCLC, and 76.9% for PCEC. The rate of typical chylous pleural effusion was 83.3% for PCLC, and 5.8% for PCEC. Symptoms and signs of PCLC were much milder than those of PCEC. The re-operation rate was 16.7% for PCLC, and 96.2% for PCEC. All patients were discharged uneventfully.
CONCLUSIONThe incidence, causes, clinical manifestations, diagnosis, and treatment of PCLC is different from those of PCEC.
